BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8640293)

  • 1. Gonadal function after multimodality treatment in men with testicular germ cell cancer.
    Palmieri G; Lotrecchiano G; Ricci G; Spiezia R; Lombardi G; Bianco AR; Torino G
    Eur J Endocrinol; 1996 Apr; 134(4):431-6. PubMed ID: 8640293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
    Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
    J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular function in patients with testicular cancer treated with orchiectomy alone or orchiectomy plus cisplatin-based chemotherapy.
    Hansen PV; Trykker H; Helkjoer PE; Andersen J
    J Natl Cancer Inst; 1989 Aug; 81(16):1246-50. PubMed ID: 2474077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
    Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
    J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer.
    Brennemann W; Stoffel-Wagner B; Wichers M; Helmers A; Albers P; Mezger J; Klingmüller D
    J Urol; 1998 Jun; 159(6):1942-6. PubMed ID: 9598493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
    Hansen SW; Berthelsen JG; von der Maase H
    J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endocrine profiles and gonadotropin response to Gn-RH of men with testicular cancer].
    Watanabe M; Fuji K; Suzuki K; Kitamura T; Okumura D; Kasahara T; Igarashi T; Masuyama T; Hiramori T; Higaki M; Yoshida H
    Nihon Hinyokika Gakkai Zasshi; 2003 Jul; 94(5):543-50. PubMed ID: 12910930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired testicular function in patients with carcinoma-in-situ of the testis.
    Petersen PM; Giwercman A; Hansen SW; Berthelsen JG; Daugaard G; Rørth M; Skakkebaek NE
    J Clin Oncol; 1999 Jan; 17(1):173-9. PubMed ID: 10458231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadal function in patients with testicular germ cell tumors.
    Tomomasa H; Oshio S; Ashizawa Y; Kamiyama Y; Okano Y; Iiyama T; Sato S; Shimizu H; Umeda T
    Arch Androl; 2002; 48(6):405-15. PubMed ID: 12425758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.
    Pectasides D; Pectasides M; Farmakis D; Nikolaou M; Koumpou M; Kostopoulou V; Mylonakis N
    Eur Urol; 2004 Feb; 45(2):187-93. PubMed ID: 14734005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadal function in men with testicular cancer.
    Petersen PM; Giwercman A; Skakkebaek NE; Rørth M
    Semin Oncol; 1998 Apr; 25(2):224-33. PubMed ID: 9562456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine and exocrine profiles of men with testicular tumors before orchiectomy.
    Carroll PR; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bajorunas D; Fair WR; Chaganti RS
    J Urol; 1987 Mar; 137(3):420-3. PubMed ID: 3029434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semen quality after treatment for testicular cancer.
    Fosså SD; Aabyholm T; Vespestad S; Norman N; Ous S
    Eur Urol; 1993; 23(1):172-6. PubMed ID: 8477777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility after high-dose chemotherapy for testicular cancer.
    Ishikawa T; Kamidono S; Fujisawa M
    Urology; 2004 Jan; 63(1):137-40. PubMed ID: 14751366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors.
    Gerl A; Mühlbayer D; Hansmann G; Mraz W; Hiddemann W
    Cancer; 2001 Apr; 91(7):1297-303. PubMed ID: 11283930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadal function in men with testis cancer.
    Berthelsen JG; Skakkebaek NE
    Fertil Steril; 1983 Jan; 39(1):68-75. PubMed ID: 6293886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ cell function and hormonal status in patients with testicular cancer.
    Hansen PV; Trykker H; Andersen J; Helkjaer PE
    Cancer; 1989 Aug; 64(4):956-61. PubMed ID: 2545331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors.
    Nijman JM; Schraffordt Koops H; Kremer J; Sleijfer DT
    J Clin Oncol; 1987 Apr; 5(4):651-6. PubMed ID: 3104546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
    Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
    Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive toxicity with and without LHRHA administration during adjuvant chemotherapy in patients with germ cell tumors.
    Kreuser ED; Hetzel WD; Hautmann R; Pfeiffer EF
    Horm Metab Res; 1990 Sep; 22(9):494-8. PubMed ID: 1701752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.